A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope
About EASL and the A-TANGO Consortium The A-TANGO Consortium, a five-year project, consists of 14 institutions across eight countries in Europe. It aims to perform Phase II clinical studies of an innovative therapeutic strategy that targets inflammation and improves liver regeneration – a novel c…